Cipla's Ugandan subsidiary plans for IPO
DSIJ Intelligence / 11 Nov 2016
Cipla Quality Chemical Industries, subsidiary company of Cipla is evaluating an initial offering. Meanwhile, Renaissance Capital (Kenya) has been appointed for its Ugandan subsidiary’s official book runner.
Cipla Quality Chemical Industries, subsidiary company of Cipla is evaluating an initial offering. Meanwhile, Renaissance Capital (Kenya) has been appointed for its Ugandan subsidiary’s official book runner.
Certain shareholders may consider selling down part or all their stake to enable sufficient free float and liquidity while Cipla Group, represented through its subsidiaries, intends to continue holding the majority stake and control.
Cipla Quality Chemical Industries’ transaction would be subject to approval of the relevant market regulators.
The share price of Cipla increased by 1.35 per cent on bourses in early trades and is trading at Rs 562.75 on an intraday basis.
Cipla Quality Chemical Industries is a state of the art pharmaceutical plant that manufactures the latest Anti-retroviral (ARVs), Anti-malarial (ACTs) and Hepatitis B medicines. CiplaQCIL was established in 2005 as a joint venture company between Cipla of India and Quality Chemicals (QCL) of Uganda.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.